tiprankstipranks
Advertisement
Advertisement
OncoSec receives $3.9M in tax credits from NJEDA program
PremiumThe FlyOncoSec receives $3.9M in tax credits from NJEDA program
3y ago
OncoSec to sell about 1.6M shares at $1.25 per share in registered direct offer
Premium
The Fly
OncoSec to sell about 1.6M shares at $1.25 per share in registered direct offer
3y ago
OncoSec announces results from Phase 2 KEYNOTE-695 clinical trial
Premium
The Fly
OncoSec announces results from Phase 2 KEYNOTE-695 clinical trial
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100